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Isolation of Functionally Different Human Monocytes by Counterflow Centrifugation Elutriation
By Carl G. Figdor, Willy S. Bont, Ivo Touw, Johan de Roos, Eddy E. Roosnek, and Jan E. de Vries
Human peripheral blood monocytes were isolated by coun­
terflow centrifugation élutriation (CCE). This technique 
was modified in such a way that various monocyte frac­
tions (viability >99% ) could be elutriated by increasing the 
density of the CCE-medium in steps of 0.0027 g/m l. All 
monocytes showed the same size distributions as deter­
mined by electronic sizing, which indicated that they 
differed in their density only. Both cytoplasmic esterase 
and peroxidase activity increased with the density of the 
cells. Furthermore, the monocytes with the highest density 
were 2 .3 -4  times more active in an antibody-dependent 
cellular cytotoxicity (ADCC) assay than those with the
Mo n o c y t e s / m a c r o p h a g e s  have beenshown to exert various important immunoregu- 
latory functions; for instance, they are required for 
optimal T-cell responsiveness and T-ceII differentia­
tion induced by mitogens1,2 and (allo)antigens3,4 and 
they play an intermediary role in the passage of 
suppressor signals between T-cell subsets.5 Until now it 
has not been clear whether the various functions are 
mediated by the same monocytes/macrophages or 
whether distinct monocyte/macrophage subsets are 
involved. Human peripheral blood monocytes have 
been found to be heterogenous, both in functional and 
biochemical properties.6"8 Furthermore, subpopula­
tions of HLA-DR-bearing monocytes that failed to 
support antigen-induced T-cell proliferation and that 
were ineffective in lymphokine production have been 
described.9 Monocyte heterogeneity has further been 
demonstrated with monoclonal antibodies that reacted 
with a 120,000-dalton determinant present on a pro­
portion of the peripheral blood monocytes. Only those 
monocytes that displayed both the 120,000-dalton 
determinant and HLA-DR but not those that had 
HLA-DR only, are effective in antigen-induced T-cell 
proliferation.10
The aim of the present study was to investigate 
whether functionally different monocytes can be iso­
lated from human blood* We have previously shown
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lowest density. In contrast, the monocytes with the high­
est density were less capable to induce the proliferation of 
lymphocytes in mixed leukocyte cultures (MLC) than those 
with the lowest density. This observation could not be 
attributed to differences in the expression of HLA-DR 
determinants, since a monoclonal antibody directed 
against HLA-DR antigens reacted equally well with the 
monocytes in different fractions. These results provide 
evidence for the existence of functionally different subsets 
of monocytes or different stages of differentiation or 
maturation.
that counterflow centrifugation élutriation (CCE) can 
be used successfully for the isolation of human mono­
cytes and lymphocytes.11,12 Here we describe a modi­
fied CCE technique that enabled us to isolate various 
monocyte fractions according to their density. These 
monocytes are shown to be different in their enzyme 
activity, antibody-dependent cellular cytotoxicity 
(ADCC), and their capacity to induce lymphocyte 
proliferation in mixed leukocyte cultures.
MATERIALS AND METHODS
Media and Reagents
Phosphate-buffered saline (PBS) with 0.14% bovine serum albu­
min (BSA) (fr. V, Sigma, St. Louis, Mo,), penicillin (100 IU/ml), 
streptomycin (50 Mg/ml) was used as standard CCE medium. 
Elutriation with medium of a higher density was achieved by mixing 
the standard CCE medium with CCE medium containing 12.5% 
Percoll (Pharmacia, Uppsala, Sweden). This medium was desig­
nated CCE-P-medium. ADCC assays and mixed leukocyte cultures 
(MLC) were carried out in Dulbecco’s modification of Eagle's 
Minimal Essential Medium (DMEM) supplemented with 5% fetal 
calf serum (FCS), glutamin, and antibiotics, all obtained from 
Gibco-Biocult, Glasgow, Scotland. Anti-D antibody was obtained 
from the Central Laboratory of the Netherlands Red Cross Blood 
Transfusion Service, Amsterdam, The Netherlands. Tritiated thy­
midine (3H-TdR, 6.7 Ci/mmole) was purchased from New England 
Nuclear (Boston, Mass.) and FïTC-conjugated goat anti-mouse 
immunoglobulin (GAM) from Nordic Diagnostics, Tilburg, The 
Netherlands. Maxidens was obtained from Nyegaard and Co, Oslo, 
Norway.
Cell Preparations
Buffy coat (BC-1) cells prepared from 500 ml blood containing 
acidic citrate dextrose (ACD) were obtained from the Central 
Laboratory of the Netherlands Red Cross Blood Transfusion Ser­
vice, Amsterdam. A  second buffy coat (BC-2) was prepared in a 
newly developed cell separator. This sandglass-resembling apparatus 
(manufactured by De Koningh B.V,, Arnhem, The Netherlands) is 
shown in Fig. 1 and was made of glass. The cell separator (without 
fractionation device) was filled with BC-1. The volume of the lower 
compartment was adjusted by means of Maxidens (a nontoxic 
autoclavable fluid, which is immiscible with blood and has a density
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Fig. 1. An apparatus for the preparation of BC-2. The blood 
cell separator is shown in cross-section and consists of two 
compartments connected with a narrow tube. During centrifuga­
tion, BC-2 is formed just below the narrow tube. After centrifuga­
tion, a fractionation device consisting of a seal, an outlet tube, and 
an inlet tube for the introduction of NaCI, is screwed on top of the 
apparatus. By means of the simultaneous injection of NaCI in the 
upper compartment and Maxidens (md) in the lower compart­
ment, fractionation of BC-2 is accomplished via the outlet tuba. 
This procedure has the advantage that the plasma acts as a sheath 
flow for the BC-2 cells and thus prevents sticking of these cells to 
the inner side of the outlet tube. In addition, BC-2 cells are 
collected without the exposure to body foreign substances, rbc, 
Red blood cells.
of 1.9 g/ml) in such a way that during centrifugation BC-2 was 
formed just below the narrow tube. The volume of Maxidens 
required could be calculated after determination of the hematocrit of 
BC-1. The apparatus was placed in a centrifuge (MSE-Mayor, 
MSE, Sussex, England), and after centrifugation for 30 min 500 gat 
room temperature, BC-2 was isolated as shown in Fig. 1.
Counterflow Centrifugation Elutriation
In order to be able to vary the density of the CCE medium, the 
élutriation system as previously described12 had to be adapted as 
shown in Fig. 2. The reservoirs R, and R2l containing CCE medium 
and CCE-P-medium, respectively, are large flat plastic bags placed 
at a height of 180 cm and filled with 2 liters of medium. The 
thickness of the bags is approximately 4 cm. Since élutriation is 
carried out at a constant flow rate of 18 ml/min and the pressure is
g
180 cm, the flow rate will decrease at about 1%/hr. These modifica­
tions made it possible to exclude the pump and the overflow as used 
previously. In this way the system was largely simplified.
Elutriation was carried out under sterile conditions. Autoclavation 
of the shaft and extensive rinsing of the other parts and tubing with 
70% ethanol was sufficient to permit long-term cultures of the
fractionated lymphoid cells.12 During elutriation, the centrifuge was 
cooled to 0°C, and the medium was cooled by passage through a 
spiral placed in alcohol of 0°C. This resulted in a temperature of the 
medium of 4°C just before entering the rotor, and 10°C just after 
leaving the rotor.
Characterization of Fractionated Cells
The fractionated cells were differentiated according to the follow­
ing criteria: (1) May-Griinwald-Giemsa (MGG) staining of cyto- 
centrifuge preparations. (2) Staining for nonspecific cytoplasmic 
esterase.14 (3) Electronic sizing on a Coulter counter ZF with a 
pulse-height analyzer (Chanalyzer model C-1000).15 (4) Pulse- 
cytophotomctry for esterase and peroxidase staining with a Hema- 
log-D apparatus (Technicon, New York). (5) Immunofluorescent 
staining with monoclonal anti-HLA-DR antibodies.
ADCC of Fractionated Cells
The various cell fractions were tested for their ADCC capacity in 
a 5,Cr release assay in which antibody-coated human erythrocytes 
were used as target cells. A quantity of 109 fresh autologous human 
erythrocytes (HE) were resuspended in 0.2 ml medium and labeled 
with 100 juCi slCr (sodium chromale, New England Nuclear, 
Boston, Mass.) for 60 min at 37°C. During the last 30 min of the 
labeling period 0.2 ml of undiluted anti-D antibody was added to the 
HE. The 51Cr-labeled antibody-coated HE were washed 3 times with 
PBS, and 2.5 x 10s erythrocytes (in 100 >itl DMEM) were seeded per 
well of an U-bottomed microtiter tesL plate (Linbro, no. 76-213-05, 
Hamden, Conn,). Various concentrations of effector cells were 
added in 100 ti\ medium. The plates were centrifuged for 2 min at 
150 g and incubated for 24 hr at 37°C in 100% humidity and 5% 
C 02. At the end of the incubation, 100 fx\ of supernatant fluid was 
collected and counted in a gamma counter. The ADCC was 
expressed as the percentage of 51Cr release, which was calculated as 
follows: {A — B jT  — B) x 100, where A is mean cpm of test 
sample; B, mean cpm of spontaneous 51 Cr release (i.e., 51Cr release 
by the labeled target cells in medium only); T, mean cpm of the 
maximal 5,Cr release that was obtained after addition of 1% Triton 
to the target cells. The average spontaneous release ±SD of the HE 
was 8% ± 2%.
The Capacity of Monocytes to Induce Lymphocyte 
Proliferation in Mixed Leukocyte Cultures
The monocytes in the various fractions were tested for their 
capacity to induce lymphocyte proliferation in mixed leukocyte 
cultures. Mononuclear cells (2 x 105) were incubated with 10s, 5 x 
104, 2.5 x 104, and 1.25 x 104 irradiated (3000 rad) monocytes in a 
final volume of 200 fi\ DMEM in flat-bottomed microtiter plates 
(3040 Falcon Plastics, Oxnard, Calif.). After 6 days of incubation at 
37°C and 5% C 0 2, the cultures were pulsed for 3 hr with 0.4 /¿Ci 
3H-thymidine (3H-TdR) per well and harvested onto glass fiber filter 
strips with an automatic sample harvester (MASH II, Microbiologi­
cal Associates, Wailkerville, Md.). 3H-TdR incorporation was 
counted in a liquid scintillation counter (Packard Instrumental 
Company, Downers Grove, III.). Each test was carried out in 
triplicate.
Immunofluorescent Staining of Monocytes With 
Monoclonal Anti-HLA-DR Antibodies
The presence of HLA-DR antigens on the monocytes in the 
various fractions was determined by direct membrane immunofluor­
escence using a monoclonal anti-HLA-DR antiserum (anti p29,34, 
kindly provided by Dr. Cox Terhorst, Sidney Farber Cancer Insti-

















Fig. 2. Schematic representation 
of elutriation system. A constant flow 
rate was generated by a hydrostatic 
pressure, p, which was determined by 
the difference in height between the 
medium level in both the reservoirs, R1 
and R2, and the outlet. The direction of 
the flow rate is indicated by arrows. 
contains the standard CCE medium 
and R2 contains the medium supple­
mented with 12.5% Percoll. The ratio 
P of these two media can be adjusted by 
means of valves V2 and V3 and moni­
tored with the flow meters f 2 and Fa. 
The media are thoroughly mixed with 
a magnetic stirrer in reservoir Ra. 
Before entering the rotor, the media 
are cooled to 0°C by passing a cooling 
spiral. Fractions were collected in 150 
ml volumes. To prevent overpressure, 
the rubber seal was perforated by a 
needle connected with a sterilization 
filter, Ft. Elutriation was carried out by 
variation of the rotor speed at a con­
stant flow rate of 18 ml/min, which 
was monitored with flow meter F,.
tute, Boston, Mass.). The monocytcs were resuspended in DMEM 
supplemented with 5% inactivated (45 min, 56°C) human AB serum 
and incubated with anti-p29,34 for 30 min at 0°C. After this 
incubation period, the monocytes were extensively washed in PBS 
containing 0.01 M  NaN3 and incubated again with 1:10 diluted 
FITC-conjugated GAM for 30 min at 0°C, The excess of the 
conjugate was removed by extensive washing with PBS containing
0.01 M  azide. After this washing procedure, the monocytes were 
collected, mounted, and counted under a fluorescence microscope as 
described previously.2 Monocytes incubated with FITC-conjugated 
GAM only were used as controls.
RESULTS
Isolation of Subsets of Human Peripheral Blood 
Monocytes
Cells of a second buffy coat (BC-2), as defined in 
Materials and Methods, were used as starting materi­
al. This cell suspension was highly enriched for leuko­
cytes. The leukocyte-erythrocyte ratio was approxi­
mately 1:10 (compared with 1:1000 in peripheral 
blood). Eighty-five percent of these leukocytes are 
mononuclear cells (Table 1) (representing 90% of the 
mononuclear cells present in BC-1), whereas the other 
cells were granulocytes. If, however, BC-2 cells were 
used as starting material, the granulocytes present in 
this cell suspension were found to contaminate the 
monocyte fractions (data not shown), indicating that 
the sedimentation velocities of both cell types are 
almost equal.
By manipulating the density of the CCE medium, 
we were able to isolate various monocyte fractions, 
which in addition were almost completely depleted of 
granulocytes (Table 1). The BC-2 cells were fraction­
ated at a constant flow rate of 18 ml/min in the 
following way: The cell sample was introduced at 3200






MGG Staining Esterase Staining
%ly % mo % gr Percent Positive Cells
Starting material 64 ± 10 21 ± 6 15 ± 6 25 ± 5
Fraction 1 3,050 1.0040 99 ± 0.5 <1 --------- <0.5
2 2,900 1.0040 99 ± 0.5 <1 --------- <1
3 2,750 1.0040 84 ± 15 13 ± 11 3 ± 3 8 ± 4
4 2,750 1.0066 31 ± 13 61 ± 12 8 ± 7 55 ± 16
5 2,750 1.0093 8 ± 3 85 ± 7 7 ± 5 82 ± 9
6 2,750 1.0119 2 ± 1 96 ± 2 2 ± 1 90 + 7
7 2,750 1.0145 4  ± 2 88 ± 5 8 + 5 86 ± 4
8 2,750 1.0172 11 ± 6 47 ± 19 42 ± 21 52 ± 15
9 2,750 1.0198 4 ± 3 11 ± 12 85 ± 10 15 ± 11
Mean ± standard deviation of 6 experiments is shown. Starting with fraction 4, the density of the elutriation medium was raised as shown in Fig. 1.
For further details of the isolation procedure, see Materials and Methods and Results.
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rpm to remove the thrombocytes and most of the 
erythrocytes. The first cell fraction was collected at 
3050 rpm and contained the rest of the erythrocytes 
and approximately 40% of the lymphocytes. The frac­
tions 2 and 3 were elutriated at 2900 and 2750 rpm, 
respectively, and contained lymphocytes. At this point 
of the separation procedure, the density of the CCE 
medium was increased, whereas the rotor speed was 
kept constant. A stepwise increase in density of the 
elutriation medium was achieved by mixing the CCE 
medium and CCE-P-medium at different ratios, as 
described in the legend of Fig. 2. To isolate monocyte 
fractions, the following ratios of CCE and CCE- 
P-medium (ml/min) were used: 15:3, 12:6, 9:9, 6:12, 
3:15, and 0:18. This implies that the density of the 
medium increased with steps of 0.0027 g/ml (Table 1) , 
Fraction 4 is an intermediate fraction (Table 1) and 
contained few cells. In fraction 5, consisting of 85% 
monocytes, 19% ± 9% of the monocytes were recov­
ered. Fractions 6 and 7 contained 88%-96% monocytes 
and 24% ± 6% and 30% ± 10% of the monocytes were 
recovered in these fractions, respectively. Fraction 8 
was contaminated with granulocytes and contained 
11% ± 4% of the monocytes. Fraction 9 was mainly 
composed of granulocytes. The monocytes present in 
this fraction represented only 4% ± 3% of the total
monocyte number. The monocytes recovered in frac­
tions 5-8 represent about 75% of all monocytes present 
in BC-1.
The viability of the cells in all fractions was >99%. 
Electronic sizing of the fractions demonstrated the 
same size distribution of all monocyte fractions (4-8) 
(not shown).
These results indicate that monocyte fractions that 
differ in density can be isolated by means of a stepwise 
increase of the density of the medium.
Enzyme Activity of the Monocyte Fractions
Both cytoplasmic peroxidase and nonspecific ester­
ase activity were measured in a Hemalog-D pulse- 
cytophotometer.16 The peroxidase activity of fractions 
5, 6, 7, and 8 was shown to increase in parallel with the 
increase of the density of the monocytes (Fig. 3). This 
phenomenon could not be attributed to an increase in 
cell size, because all monocyte fractions had the same 
size distribution profile as measured electronically. 
The fractions 5, 6, and 7 had the same size distribution 
as measured by light scatter in the Hemalog-D (Fig. 
3). The increase in size of the cells in fraction 8 
(illustrated by the upward shift of the scatter along the 
Y axis) has to be attributed to a 42% contamination
Fig. 3. Peroxidase activity 
in the monocyte fractions. The 
peroxidase activity of the cells 
present in fractions 5, 6 ,1, and 
8 were measured with a hema- 
log-D pulse cytophotometer. 
The Y axis represents the scat­
ter (cell size) and the X axis 
represents the enzyme content 
per cell. The granulocytes were 
displayed as larger cells than 
the monocytes, due to scatter­
ing of internal structures of
6
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Fig. 4. Esterase activity in 
the monocyte fractions. The 
esterase activity of the cells 
present in fractions 5, 6, 7, and 
8 were measured with a hema- 
log-D pulse cytophotometer. 
The Y axis represents the scat­
ter (cell size) and the X axis 
represents the enzyme content 
per cell.
with granulocytes, which also contain peroxidase activ­
ity (see legend to Fig. 3).
The content of cytoplasmic nonspecific esterase of 
the various monocyte fractions was also shown to 
increase in parallel with the increase in density of these 
cells (Fig. 4). The small scatter spots in the lower left 
corners of fractions 5 and 8 were due to minimal 
lymphocyte contaminations (see also Table 1). In spite 
of the fact that the same chemicals were used, the 
percentage of esterase-positive cells detected by the 
Hemalog-D (Table 2) was always lower than the 
percentage esterase-positive cells obtained with the 
esterase staining procedure described by Lawrence 
and Grossman.14 Since the latter procedure was car­
ried out on cytocentrifuge preparations that were 
counted under the microscope (Table 1), the discrep­
ancy could be explained by the lower sensitivity of the 
Hemalog-D apparatus (due to threshold setting) com­
pared to the human eye, which is illustrated by the 
relatively large number of “large unstained cells” 
scored by the Hemalog-D apparatus (Table 2). Fur­
thermore, it is shown that the number of “large
unstained cells” decreased with increasing cell density, 
indicating again that enzyme activity increased with 
the cell density.
ADCC of the Fractionated Cells
The monocyte fractions obtained by elutriation were 
tested on their capacity to lyse anti-D-coated autolo­
gous erythrocytes. The effector/ target cell ratios were
1, 0.5, 0.3, 0.2, and 0.1. Afterwards, the E/T ratios
Table 2. Percent Monocytes and Large Unstained Cells 







Fraction 5 55 20 75
Fraction 6 77 10 87
Fraction 7 80 8 88
Fraction 8 72 4 76
The sum of the percent of monocytes and large unstained cells equals 
the amount of monocytes as determined by the manual esterase staining 
(see Table 1).
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were converted to 100% monocytes in each fraction (as 
judged by esterase staining), so that the number of 
lytic units/107 monocytes could be calculated. In this 
way, the various fractions were directly comparable 
(Table 3). Maximal ADCC was observed in the mono- 
cyte fractions with the highest density. These cells 
were 2,3-4 times more active than the cells with the 
lowest density. Purified granulocytes and lymphocytes, 
which contaminate these fractions, are ineffective in 
this ADCC.12 From these data it can be concluded that 
there is a positive correlation between the density of 
the monocytes and their ADCC activity. Activation of 
the monocytes by Percoll, which possibly might 
influence the ADCC, could be excluded, since incuba­
tion of monocytes for 3 hr with 5%, 10%, or 15% 
Percoll had no effect on their activity in ADCC. 
Furthermore, identical results were obtained if the 
separation procedure was carried out with Isopaque 
instead of Percoll.
The lack of ADCC activity of highly purified lym­
phocytes could not be attributed to lymphocyte defects 
introduced by the separation procedure, since stimula­
tion with phytohemagglutinin (PHA) in the presence 
of monocytes resulted in 3 H-thymidine uptake, which 
was comparable to that of the corresponding unfrac­
tionated lymphocytes (De Vries et al., unpublished 
results). Finally, the low ADCC of fraction 4 cells 
could not be attributed to suppressive effects of the 
lymphocytes present in this fraction, since no decrease 
in ADCC of the monocyte fractions 5, 6, and 7 was 
observed after addition of fraction 4 cells.
The Capacity of the Monocytes in the Various 
Fractions to Induce Lymphocyte Proliferation
in MLC
Various concentrations of the monocytes in fractions 
5, 6, and 7 were used as stimulator cells in MLC in
Table 3. ADCC of the Fractionated Monocytes
Lytic Units/107Monocytes
Fraction Number exp 1 exp 2 exp 3 exp 4 exp 5 exp 6
Starting material 221 99 146 223 NT 2 4 0
4 111 NT NT 129 137 148
5 161 55 100 2 0 0 NT 2 1 0
6 266 78 153 2 1 0 2 1 0 267
7 162 105 190 2 5 0 NT 307
8 287 235 388 333 3 2 0 4 0 0
51Cr release of autologous anti-D-coated erythrocytes was measured 
by adding cells from fractions 4 to 8. Effector/target cell ratios were 1, 
0.5, 0.3, 0.2, and 0.1, To compare the results from the different 
fractions, the E/T ratios were converted afterwards to 100% monocytes 
in each fraction (as judged by esterase staining), so that the number of 
lytic units/107 monocytes could be calculated. One lytic unit equals the 













Fig. 5. Lymphocyte proliferation-inducing capacity of the vari­
ous monocyte fractions. Fractions 5 { •) , 6 (A), and 7 (O) mono­
cytes were used as stimulator cells in MLC in which UL were used 
as responder cells. The proliferation of UL stimulated with 25% 
fraction 5 cells was set at 100% in each experiment. The mean 
percent proliferation and SEM of 6 experiments are shown. **p <  
0 .0 1 ;%  < 0 .0 5 .
which unseparated leukocytes (UL) were used as 
responder cells. The capacity to induce lymphocyte 
proliferation correlated negatively with the density of 
the monocytes (Fig. 5). Fraction 5 cells were most 
effective in inducing lymphocyte proliferation, 
whereas the monocytes of fraction 7 were the least 
effective. Optimal proliferation with all three mono­
cyte fractions was induced at monocyte concentrations 
of 25%, whereas monocytes added at a concentration 
of 50% were generally less effective in inducing lym­
phocyte proliferation. The differences in the capacity 
to induce lymphocyte proliferation could not be attrib­
uted to differences in the expression of HLA-DR 
antigens, since the monocytes in fractions 5-7 were 
>97% HLA-DR positive, whereas in addition, no 
significant differences in the intensity of fluorescence 
were observed.
DISCUSSION
CCE has been shown to be a very efficient procedure 
for the isolation of large numbers of human lympho­
cytes and monocytes from peripheral blood.11,12,16-18 
We previously described that lymphocytes and mono­
cytes can be separated from mononuclear leukocyte 
samples that were obtained by centrifugation of 
peripheral blood over Ficoll/Hypaque mixtures.12 
Here we demonstrate that this laborious Ficoll/Hypa­
que step can be omitted and that the BC-2 cells can be 
introduced directly into the elutriator rotor if they are
6.2 12.5 25 50
percentage monocytes added
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prepared with the cell separator as described in Mate­
rials and Methods. By means of this technique, BC-2 
cells can be collected without exposure to body foreign 
substances that might affect their physical and func­
tional properties.
Increase in density of the CCE medium during 
élutriation not only prevents contamination of the 
monocytes with granulocytes but also enables us to 
separate monocyte subpopulations that differ in densi­
ty*
Introduction of a density gradient in the system 
requires a second reservoir with CCE-P-medium. 
However, introduction of a second reservoir in the 
system described previously would make it too complex 
to handle. Therefore, in the present system, the pump 
and the overflow were replaced by large, flat, soft 
plastic containers. The constancy of the flow rate was 
not significantly affected by these alterations in the 
system, since the decrease of the flow rate was only 
1%/hr. This is acceptable, especially if the simplifica­
tion of the system is taken into account.
To prevent lymphocyte contamination of the mono­
cyte fractions, the increase in density of the CCE 
medium can only be started after the lymphocytes have 
been elutriated. A stepwise increase in the density of 
the medium of only 0.0027 g/ml proved to be sufficient 
to isolate various monocyte fractions. The monocytes 
in these fractions had the same size distribution as 
judged by electronic sizing, indicating that they only 
differ in their density. The results showed that a 
physical property of the monocytes, like their density, 
is correlated with their functions; a positive correlation 
between density enzyme content and ADCC activity 
was observed. Preliminary data furthermore indicated 
that hydrogen peroxide production during phagocyto­
sis of serum-treated zymosan (STZ) increased in 
parallel with the increase in density of the monocytes
„  ■ t m
(Roosnek et al., manuscript in preparation).
Less dense monocytes (fraction 5) induced signifi­
cantly stronger T-cell proliferation in MLC than did 
the more dense monocytes (fractions 6 and 7). We 
previously reported that the T-cell-induced prolifera­
tion by monocytes in MLC was mediated by HLA-DR 
antigens present on the monocytes.19 However, the 
differences in T-ceil-inducing capacity of the mono­
cyte fractions 5, 6, and 7 could not readily be attrib­
uted to differences in the expression of HLA-DR 
antigens, as judged by fluorescence microscopy, and 
are probably due to other metabolic differences 
between these cells.
Norris et al.,17 and recently also Yasaka et aL,20 
reported the isolation by CCE of “small” and “large” 
monocytes that differed in function. The results
obtained by Norris et al. may be explained by the fact 
that the cell population designated by these authors as 
small monocytes actually represent the contaminating 
lymphocyte population, which implies that the bimodal 
size distribution profiles observed here to be attributed 
to lymphocytes and monocytes and not to “small” and 
“large” monocytes. In addition, the size distribution 
profile of the intermediate fraction (containing lym­
phocytes and monocytes) of Norris et al. indicates that 
the monocytes in this fraction are primarily large 
monocytes instead of small ones, as was concluded by 
these authors. Our results are in line with those of 
Contreras et al.,18 who were unable to demonstrate 
bimodal size distribution of small and large mono­
cytes .
Furthermore, it has to be stressed that it is not 
allowed to determine the volume of monocytes directly 
from the size distributions of mixtures of lymphocytes 
and monocytes. Since the peaks of these two popula­
tions overlap, a careful analysis of the profiles is 
required. The apparent differences in size of the vari­
ous monocyte subpopulations, as reported by Yasaka 
et al.,20 can therefore be attributed to lymphocyte 
contamination. This can be illustrated by the size 
distributions of their unfractionated mononuclear cell 
suspensions; the volume of the monocytes in these cell 
suspensions (65% lymphocytes, 35% monocytes) 
equals the volume of the “small” monocytes, although 
this type, according to the authors, represents only 25% 
of the total monocyte populations. Our results indicate 
that the physical differences between the various sub­
sets of monocytes are primarily related to density and 
not to size.
The present study strongly suggests that monocytes 
that differ in morphological and functional criteria 
exist. It was not clear until now whether these mono­
cytes represent various subsets or different matura­
tion/differentiation stages of these cells. Because 
macrophage differentiation was shown to be accompa­
nied by a loss of peroxidase positive cytoplasmic gran­
ules,21,22 it may be concluded that the low density 
monocytes represent the most and the high density 
monocytes the least differentiated monocytes.
However, since tissue macrophages, which are con­
sidered to be the differentiation endpoint of monocytes, 
still have been shown to contain considerable quanti­
ties of both esterase and peroxidase,23 it is not unlikely 
that the maturation or differentiation of the monocytes 
is following an opposite direction than was suggested 
by in vitro studies;20,22 This could imply that the most 
dense monocytes containing the highest peroxidase 
and esterase activity are the most mature cells. Accu­
rate estimation of the esterase and peroxidase activities
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of isolated tissue macrophages may help us obtain a 
better insight in the maturation pathway of mono­
cytes.
Finally, preliminary analysis of the distribution of 
monocytes according to their differentiation/matura­
tion stages in the hemalog-D showed abnormal distri­
bution profiles. Depending on the individual donors, 
shifts to more mature or more immature monocytes 
have been observed (unpublished observations). Shifts
in these populations may explain the defects in mono-
• • • i
cyte functions described in cancer patients24 and 
deserve further investigation.
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